What is Jorgensen Laboratories?
Jorgensen Laboratories operates as a specialized veterinary distributor, providing a comprehensive suite of medical supplies and diagnostic equipment to practitioners. The company distinguishes itself through a high-touch service model, enabling clients to connect directly with regional managers while maintaining access to an extensive library of technical product literature. By prioritizing quality and product diversity, Jorgensen Laboratories has established a reliable market position as a critical intermediary in the animal healthcare ecosystem, ensuring that veterinary clinics have the necessary tools to maintain high standards of care.
How much funding has Jorgensen Laboratories raised?
Jorgensen Laboratories has raised a total of $37.4M across 2 funding rounds:
Debt
$1M
Private Equity
$36.4M
Debt (2020): $1M with participation from PPP
Private Equity (2022): $36.4M led by Main Street Capital
Key Investors in Jorgensen Laboratories
Main Street Capital
A principal investment firm providing long-term debt and equity capital to lower middle market companies, focusing on management buyouts and growth financings.
PPP
Public-Private Partnership
What's next for Jorgensen Laboratories?
With the recent infusion of capital, Jorgensen Laboratories is expected to prioritize the optimization of its logistics network and the expansion of its digital procurement platforms. The strategic focus will likely shift toward enhancing supply chain resilience and broadening the product portfolio to meet the evolving demands of the veterinary industry. As the company transitions into this next phase of enterprise-level growth, stakeholders will be monitoring its ability to integrate these resources into improved service delivery and increased market share, effectively leveraging its established reputation to capture emerging opportunities in the veterinary distribution landscape.
See full Jorgensen Laboratories company page
